Paper41312349
Benzodiazepines versus non-benzodiazepine antiseizure medications as first-line agents for status epilepticus: analysis of real word data from a 9-years prospective cohort.
Brigo F and 9 others. Front Neurol, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Benzodiazepines versus non-benzodiazepine antiseizure medications as first-line agents for status epilepticus: analysis of real word data from a 9-years prospective cohort. Papers, record 41312349. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41312349
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Benzodiazepines versus non-benzodiazepine antiseizure medications as first-line agents for status epilepticus: analysis of real word data from a 9-years prospective cohort.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22899399 | Treatment deviating from guidelines does not influence status epilepticus prognosis. | J Neurol | 2013 | https://conductscience.org/library/papers/22899399 | PubMed |
| 2 | 3922751 | Physiologic consequences of status epilepticus. | Epilepsia | 1985 | https://conductscience.org/library/papers/3922751 | PubMed |
| 3 | 39799791 | Use of benzodiazepines in patients with status epilepticus requiring second-line antiseizure medication treatment. | Epilepsy Res | 2025 | https://conductscience.org/library/papers/39799791 | PubMed |
| 4 | 26900382 | Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. | Epilepsy Curr | 2016 | https://conductscience.org/library/papers/26900382 | PubMed |
| 5 | 39707958 | Prognostic factors and impact of management strategies for status epilepticus: The STEPPER study in the Emilia-Romagna region, Italy. | Epilepsia | 2025 | https://conductscience.org/library/papers/39707958 | PubMed |
| 6 | 25952268 | Preliminary results of the global audit of treatment of refractory status epilepticus. | Epilepsy Behav | 2015 | https://conductscience.org/library/papers/25952268 | PubMed |
| 7 | 31766004 | Management of status epilepticus in adults. Position paper of the Italian League against Epilepsy. | Epilepsy Behav | 2020 | https://conductscience.org/library/papers/31766004 | PubMed |
| 8 | 27694014 | Status epilepticus in the elderly-A retrospective study on 120 patients. | Epilepsy Res | 2016 | https://conductscience.org/library/papers/27694014 | PubMed |
| 9 | 22528274 | Guidelines for the evaluation and management of status epilepticus. | Neurocrit Care | 2012 | https://conductscience.org/library/papers/22528274 | PubMed |
| 10 | 30478910 | Epidemiology of status epilepticus in adults: A population-based study on incidence, causes, and outcomes. | Epilepsia | 2019 | https://conductscience.org/library/papers/30478910 | PubMed |
| 11 | 37597263 | Acute symptomatic status epilepticus: Splitting or lumping? A proposal of classification based on real-world data. | Epilepsia | 2023 | https://conductscience.org/library/papers/37597263 | PubMed |
| 12 | 27571157 | Diagnostic accuracy of the Salzburg EEG criteria for non-convulsive status epilepticus: a retrospective study. | Lancet Neurol | 2016 | https://conductscience.org/library/papers/27571157 | PubMed |
| 13 | 26092326 | Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus--approach to clinical application. | Epilepsy Behav | 2015 | https://conductscience.org/library/papers/26092326 | PubMed |
| 14 | 22335736 | Intramuscular versus intravenous therapy for prehospital status epilepticus. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22335736 | PubMed |
| 15 | 21914716 | The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. | Brain | 2011 | https://conductscience.org/library/papers/21914716 | PubMed |
| 16 | 26627366 | Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial. | Lancet Neurol | 2016 | https://conductscience.org/library/papers/26627366 | PubMed |
| 17 | 30159884 | SENSE registry for status epilepticus. | Epilepsia | 2018 | https://conductscience.org/library/papers/30159884 | PubMed |
| 18 | 29705433 | Outcomes of deviation from treatment guidelines in status epilepticus: A systematic review. | Seizure | 2018 | https://conductscience.org/library/papers/29705433 | PubMed |
| 19 | 26629986 | Pharmacologic treatment of status epilepticus. | Expert Opin Pharmacother | 2016 | https://conductscience.org/library/papers/26629986 | PubMed |
| 20 | 26336950 | A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus. | Epilepsia | 2015 | https://conductscience.org/library/papers/26336950 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42501318 | Emergency treatment delay and underdosing are associated with poor outcome in non-convulsive status epilepticus. | Epilepsia | 2026 | https://conductscience.org/library/papers/42501318 | PubMed |
| 42159101 | Treatment adequacy outweighs treatment sequence in non-convulsive status epilepticus. | Epilepsia | 2026 | https://conductscience.org/library/papers/42159101 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41312349
GET https://conductscience.org/api/papers/v1/41312349/references?page=2